Christopher J. Senner

CIK 1648367 · EVP and CFO · last filed 2026-05-19

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$52.60M

Companies

3

Total Filings

65

Lifetime Open-Market Net

-$24.02M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EXEL EVP and CFO 989,941 $53.13 $52.60M -$24.02M 57 2026-05-19
QNCX Director $0.93 $0 5 2026-01-21
Quince Therapeutics, Inc. (CRTX) Delisted Director $1.95 $0 3 2022-06-09

Recent Filings · Page 2 of 7

65 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-02-19 EXEL Tax (F) −21,591 -$755.7K EDGAR
2025-01-17 EXEL Mixed +97,024 -$1.34M EDGAR
2025-01-08 QNCX Grant (A) $0 EDGAR
2024-11-19 EXEL Tax (F) −17,506 -$613.6K EDGAR
2024-08-09 EXEL Mixed -$347.5K EDGAR
2024-06-07 QNCX Grant (A) $0 EDGAR
2024-05-17 EXEL Tax (F) −30,310 -$636.2K EDGAR
2024-02-27 EXEL Grant (A) +82,121 $0 EDGAR
2024-01-16 EXEL Mixed +58,324 -$499.8K EDGAR
2023-09-08 EXEL Mixed +47,988 -$381.9K EDGAR
Showing 1120 of 65
Page 2 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.